Cargando…

Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate despite advances in diagnostic and therapeutic strategies. In recent years, significant scientific progress has been made in the understanding of the underlying pathobiological mechanisms. Since current available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin de Miguel, Irene, Cruz-Utrilla, Alejandro, Oliver, Eduardo, Escribano-Subias, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965798/ https://www.ncbi.nlm.nih.gov/pubmed/36835558 http://dx.doi.org/10.3390/ijms24044147

Ejemplares similares

Expanding the Evidence of a Semi-Dominant Inheritance in GDF2 Associated with Pulmonary Arterial Hypertension
por: Gallego, Natalia, et al.
Publicado: (2021)

Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature
por: Gallego-Zazo, Natalia, et al.
Publicado: (2022)

Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2021)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
por: Nuche, Jorge, et al.
Publicado: (2020)

COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
por: Segura de la Cal, Teresa, et al.
Publicado: (2021)

Clinical course of COVID-19 in pulmonary arterial hypertension patients
por: Nuche, Jorge, et al.
Publicado: (2020)

The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned?
por: Hinojosa, Williams, et al.
Publicado: (2022)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension
por: Pienkos, Shaun, et al.
Publicado: (2021)

Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2021)

Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients
por: Lago-Docampo, Mauro, et al.
Publicado: (2020)

Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy
por: Maneiro Melon, Nicolas M., et al.
Publicado: (2023)

Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension
por: Callejo, Maria, et al.
Publicado: (2020)

Clinical Implications of the Genetic Background in Pediatric Pulmonary Arterial Hypertension: Data from the Spanish REHIPED Registry
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2022)

Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature
por: Gallego-Zazo, Natalia, et al.
Publicado: (2023)

Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension
por: Cunningham, Kevin P., et al.
Publicado: (2018)

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study
por: Escribano-Subias, Pilar, et al.
Publicado: (2020)

Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension
por: Nuche, Jorge, et al.
Publicado: (2020)

Vitamin D deficiency among patients with pulmonary hypertension
por: Atamañuk, Andrés N., et al.
Publicado: (2019)

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
por: Garcia, Agustin R., et al.
Publicado: (2023)

Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA class
por: Santos-Lozano, Alejandro, et al.
Publicado: (2017)

Customized Massive Parallel Sequencing Panel for Diagnosis of Pulmonary Arterial Hypertension
por: Castaño, Jair Antonio Tenorio, et al.
Publicado: (2020)

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
por: Humbert, Marc, et al.
Publicado: (2023)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2020)

Lung and heart-lung transplantation in pulmonary arterial hypertension
por: López-Meseguer, Manuel, et al.
Publicado: (2017)

Balloon pulmonary angioplasty can be an effective and safe therapeutic option in non-surgical elderly patients
por: Velázquez Martín, Maite, et al.
Publicado: (2022)

The Molecular Genetics and Cellular Mechanisms Underlying Pulmonary Arterial Hypertension
por: Machado, Rajiv D.
Publicado: (2012)

Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension
por: López-Meseguer, Manuel, et al.
Publicado: (2018)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Potential mechanisms and serum biomarkers involved in sex differences in pulmonary arterial hypertension
por: Li, Chan, et al.
Publicado: (2020)

Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension
por: Morrell, Nicholas W., et al.
Publicado: (2013)

Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report
por: Araújo, Inês, et al.
Publicado: (2011)

Molecular Pathways in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2022)

Repurposing of medications for pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2020)

Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients
por: Segura de la Cal, Teresa, et al.
Publicado: (2020)

An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension
por: Simon, Marc A., et al.
Publicado: (2022)

Mechanisms of disease: pulmonary arterial hypertension
por: Schermuly, Ralph T., et al.
Publicado: (2011)

Evaluation of a digital health system (PAHcare™) for routine care of patients with pulmonary arterial hypertension: The CBS-PAH study protocol
por: Pérez Peñate, Gregorio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48p48jasmnve1havu8v43na6oj